Project Grant HT94252310682
Award Date
7/1/23
Completion Date
6/30/26
Dollars Obligated
$998K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Buffalo, NY 14228, USA
Similar Awards
The Department of the Army Medical Command awarded a $1,463,982 Project Grant to The Research Foundation for the State University of New York (RF SUNY) under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year research project titled "Defining the ABI1-Mediated Resistance to Enzalutamide" to investigate new treatments for military health priorities. The Research Foundation for the State University of New York, which serves as the fiscal...
The U.S. Department of Defense's Defense Health Agency has awarded a $1,179,730 Project Grant to The Research Foundation for the State University of New York (RF-SUNY) at the University at Albany. The grant, under the Military Medical Research and Development program (CFDA 12.420), will fund research to identify new biological and therapeutic targets for myotonic dystrophy type 1, a genetic disorder affecting muscle function. The four-year grant, which began on April 1, 2024, will support basic,...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,938,711 Project Grant to The Research Foundation for the State University of New York (RF-SUNY) on April 1, 2024. The grant will fund research to identify new biological and therapeutic targets for myotonic dystrophy type 1, a genetic disorder that causes progressive muscle weakness and wasting. The project aims to transform health care for service members and the public by conducting...
This federal Project Grant award of $554,875.00 was awarded on March 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Research Foundation for the State University of New York (RF SUNY). The funding will support a 3-year research project titled "TRANSLATION DYSREGULATION IN METASTATIC BREAST CANCER: IMPLICATIONS FOR DISEASE AND IMMUNOTHERAPY OUTCOMES". The objective is to investigate the role of translational...
This federal Project Grant award of $673,448.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award was granted to The Research Foundation For The State University Of New York (RF SUNY) to conduct research on the "MALADAPTIVE 5-HT RAPHE-CORTICOLIMBIC PLASTICITY UNDERLYING THE...
This Project Grant award valued at $3,255,124.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Research Foundation for the State University of New York (SUNY). The grant funds a multi-year project to develop a "multimodal nanotrap" aimed at alleviating acute respiratory distress syndrome (ARDS) in traumatic injuries. The Research Foundation for SUNY, serving as the sponsored programs administrator for the SUNY...
The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
The federal Project Grant award of $3,300,817.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at the Icahn School of Medicine at Mount Sinai (ISMMS) to leverage personalized stem cell therapy and overcome airway reconstruction challenges. This research aims to transform healthcare for military service members, veterans, and the broader public by addressing critical health...
This $993,283 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of California, San Francisco (UCSF) aimed at transforming healthcare for military service members, veterans, and the broader public. The 2-year award, effective from September 1, 2025 to August 31, 2027, will fund proteomic research to investigate determinants and components of disease progression in multiple...
The Research Foundation for the State University of New York (RF-SUNY) was awarded $768,825 under the Military Medical Research and Development grant program (CFDA 12.420) by the Defense Health Agency to test RNA aptamers in the SOD1 G93A ALS mouse model from September 1, 2023 to August 31, 2025. This funding will support RF-SUNY's research at the University at Albany to investigate medical solutions for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, by exploring the...